Novel role for galectin-1 in T-cells under physiological and pathological conditions

Magdolna Deák, Ákos Hornung, Julianna Novák, Dmytro Demydenko, Eniko Szabó, Ágnes Czibula, R. Fajka-Boja, Éva Kriston-Pál, Éva Monostori, László Kovács

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Secreted, extracellular galectin-1 (exGal-1) but not intracellular Gal-1 (inGal-1) has been described as a strong immunosuppressive protein due to its major activity of inducing apoptosis of activated T-cells. It has previously been reported that T-cells express Gal-1 upon activation, however its participation in T-cell functions has remained largely elusive. To determine function of Gal-1 expressed by activated T-cells we have carried out a series of experiments. We have shown that Gal-1, expressed in Gal-1-transgenic Jurkat cells or in activated T-cells, remained intracellularly indicating that Gal-1-induced T-cell death was not a result of an autocrine effect of the de novo expressed Gal-1. Rather, a particular consequence of the inGal-1 expression was that T-cells became more sensitive to exGal-1 added either as a soluble protein or bound to the surface of a Gal-1-secreting effector cell. This was also verified when the susceptibility of activated T-cells from wild type or Gal-1 knockout mice to Gal-1-induced apoptosis were compared. Murine T-cells expressing Gal-1 were more sensitive to the cytotoxicity of the exGal-1 than their Gal-1 knockout counterparts. We also conducted a study with activated T-cells from patients with systemic lupus erythematosus (SLE), a disease in which dysregulated T-cell apoptosis has been well described. SLE T-cells expressed lower amounts of Gal-1 than healthy T-cells and were less sensitive to exGal-1. These results suggested a novel role of inGal-1 in T-cells as a regulator of T-cell response to exGal-1, and its likely contribution to the mechanism in T-cell apoptosis deficiency in lupus.

Original languageEnglish
Pages (from-to)483-489
Number of pages7
JournalImmunobiology
Volume220
Issue number4
DOIs
Publication statusPublished - Apr 1 2015

Fingerprint

Galectin 1
T-Lymphocytes
Apoptosis
Systemic Lupus Erythematosus
Jurkat Cells

Keywords

  • Activated T-cells
  • Apoptosis
  • Intracellular galectin-1
  • Systemic lupus erythematosus

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Deák, M., Hornung, Á., Novák, J., Demydenko, D., Szabó, E., Czibula, Á., ... Kovács, L. (2015). Novel role for galectin-1 in T-cells under physiological and pathological conditions. Immunobiology, 220(4), 483-489. https://doi.org/10.1016/j.imbio.2014.10.023

Novel role for galectin-1 in T-cells under physiological and pathological conditions. / Deák, Magdolna; Hornung, Ákos; Novák, Julianna; Demydenko, Dmytro; Szabó, Eniko; Czibula, Ágnes; Fajka-Boja, R.; Kriston-Pál, Éva; Monostori, Éva; Kovács, László.

In: Immunobiology, Vol. 220, No. 4, 01.04.2015, p. 483-489.

Research output: Contribution to journalArticle

Deák, M, Hornung, Á, Novák, J, Demydenko, D, Szabó, E, Czibula, Á, Fajka-Boja, R, Kriston-Pál, É, Monostori, É & Kovács, L 2015, 'Novel role for galectin-1 in T-cells under physiological and pathological conditions', Immunobiology, vol. 220, no. 4, pp. 483-489. https://doi.org/10.1016/j.imbio.2014.10.023
Deák M, Hornung Á, Novák J, Demydenko D, Szabó E, Czibula Á et al. Novel role for galectin-1 in T-cells under physiological and pathological conditions. Immunobiology. 2015 Apr 1;220(4):483-489. https://doi.org/10.1016/j.imbio.2014.10.023
Deák, Magdolna ; Hornung, Ákos ; Novák, Julianna ; Demydenko, Dmytro ; Szabó, Eniko ; Czibula, Ágnes ; Fajka-Boja, R. ; Kriston-Pál, Éva ; Monostori, Éva ; Kovács, László. / Novel role for galectin-1 in T-cells under physiological and pathological conditions. In: Immunobiology. 2015 ; Vol. 220, No. 4. pp. 483-489.
@article{8bcf73db69114573bbdbf2b26d741d52,
title = "Novel role for galectin-1 in T-cells under physiological and pathological conditions",
abstract = "Secreted, extracellular galectin-1 (exGal-1) but not intracellular Gal-1 (inGal-1) has been described as a strong immunosuppressive protein due to its major activity of inducing apoptosis of activated T-cells. It has previously been reported that T-cells express Gal-1 upon activation, however its participation in T-cell functions has remained largely elusive. To determine function of Gal-1 expressed by activated T-cells we have carried out a series of experiments. We have shown that Gal-1, expressed in Gal-1-transgenic Jurkat cells or in activated T-cells, remained intracellularly indicating that Gal-1-induced T-cell death was not a result of an autocrine effect of the de novo expressed Gal-1. Rather, a particular consequence of the inGal-1 expression was that T-cells became more sensitive to exGal-1 added either as a soluble protein or bound to the surface of a Gal-1-secreting effector cell. This was also verified when the susceptibility of activated T-cells from wild type or Gal-1 knockout mice to Gal-1-induced apoptosis were compared. Murine T-cells expressing Gal-1 were more sensitive to the cytotoxicity of the exGal-1 than their Gal-1 knockout counterparts. We also conducted a study with activated T-cells from patients with systemic lupus erythematosus (SLE), a disease in which dysregulated T-cell apoptosis has been well described. SLE T-cells expressed lower amounts of Gal-1 than healthy T-cells and were less sensitive to exGal-1. These results suggested a novel role of inGal-1 in T-cells as a regulator of T-cell response to exGal-1, and its likely contribution to the mechanism in T-cell apoptosis deficiency in lupus.",
keywords = "Activated T-cells, Apoptosis, Intracellular galectin-1, Systemic lupus erythematosus",
author = "Magdolna De{\'a}k and {\'A}kos Hornung and Julianna Nov{\'a}k and Dmytro Demydenko and Eniko Szab{\'o} and {\'A}gnes Czibula and R. Fajka-Boja and {\'E}va Kriston-P{\'a}l and {\'E}va Monostori and L{\'a}szl{\'o} Kov{\'a}cs",
year = "2015",
month = "4",
day = "1",
doi = "10.1016/j.imbio.2014.10.023",
language = "English",
volume = "220",
pages = "483--489",
journal = "Immunobiology",
issn = "0171-2985",
publisher = "Urban und Fischer Verlag GmbH und Co. KG",
number = "4",

}

TY - JOUR

T1 - Novel role for galectin-1 in T-cells under physiological and pathological conditions

AU - Deák, Magdolna

AU - Hornung, Ákos

AU - Novák, Julianna

AU - Demydenko, Dmytro

AU - Szabó, Eniko

AU - Czibula, Ágnes

AU - Fajka-Boja, R.

AU - Kriston-Pál, Éva

AU - Monostori, Éva

AU - Kovács, László

PY - 2015/4/1

Y1 - 2015/4/1

N2 - Secreted, extracellular galectin-1 (exGal-1) but not intracellular Gal-1 (inGal-1) has been described as a strong immunosuppressive protein due to its major activity of inducing apoptosis of activated T-cells. It has previously been reported that T-cells express Gal-1 upon activation, however its participation in T-cell functions has remained largely elusive. To determine function of Gal-1 expressed by activated T-cells we have carried out a series of experiments. We have shown that Gal-1, expressed in Gal-1-transgenic Jurkat cells or in activated T-cells, remained intracellularly indicating that Gal-1-induced T-cell death was not a result of an autocrine effect of the de novo expressed Gal-1. Rather, a particular consequence of the inGal-1 expression was that T-cells became more sensitive to exGal-1 added either as a soluble protein or bound to the surface of a Gal-1-secreting effector cell. This was also verified when the susceptibility of activated T-cells from wild type or Gal-1 knockout mice to Gal-1-induced apoptosis were compared. Murine T-cells expressing Gal-1 were more sensitive to the cytotoxicity of the exGal-1 than their Gal-1 knockout counterparts. We also conducted a study with activated T-cells from patients with systemic lupus erythematosus (SLE), a disease in which dysregulated T-cell apoptosis has been well described. SLE T-cells expressed lower amounts of Gal-1 than healthy T-cells and were less sensitive to exGal-1. These results suggested a novel role of inGal-1 in T-cells as a regulator of T-cell response to exGal-1, and its likely contribution to the mechanism in T-cell apoptosis deficiency in lupus.

AB - Secreted, extracellular galectin-1 (exGal-1) but not intracellular Gal-1 (inGal-1) has been described as a strong immunosuppressive protein due to its major activity of inducing apoptosis of activated T-cells. It has previously been reported that T-cells express Gal-1 upon activation, however its participation in T-cell functions has remained largely elusive. To determine function of Gal-1 expressed by activated T-cells we have carried out a series of experiments. We have shown that Gal-1, expressed in Gal-1-transgenic Jurkat cells or in activated T-cells, remained intracellularly indicating that Gal-1-induced T-cell death was not a result of an autocrine effect of the de novo expressed Gal-1. Rather, a particular consequence of the inGal-1 expression was that T-cells became more sensitive to exGal-1 added either as a soluble protein or bound to the surface of a Gal-1-secreting effector cell. This was also verified when the susceptibility of activated T-cells from wild type or Gal-1 knockout mice to Gal-1-induced apoptosis were compared. Murine T-cells expressing Gal-1 were more sensitive to the cytotoxicity of the exGal-1 than their Gal-1 knockout counterparts. We also conducted a study with activated T-cells from patients with systemic lupus erythematosus (SLE), a disease in which dysregulated T-cell apoptosis has been well described. SLE T-cells expressed lower amounts of Gal-1 than healthy T-cells and were less sensitive to exGal-1. These results suggested a novel role of inGal-1 in T-cells as a regulator of T-cell response to exGal-1, and its likely contribution to the mechanism in T-cell apoptosis deficiency in lupus.

KW - Activated T-cells

KW - Apoptosis

KW - Intracellular galectin-1

KW - Systemic lupus erythematosus

UR - http://www.scopus.com/inward/record.url?scp=84952719961&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84952719961&partnerID=8YFLogxK

U2 - 10.1016/j.imbio.2014.10.023

DO - 10.1016/j.imbio.2014.10.023

M3 - Article

VL - 220

SP - 483

EP - 489

JO - Immunobiology

JF - Immunobiology

SN - 0171-2985

IS - 4

ER -